Childhood cancer survival in Europe
Annals of OncologyPublished 1 December 2003Open access
Gemma Gatta, Isabella Corazziari, Corrado Magnani, Rafael Peris‐Bonet, P. Roazzi, Charles Stiller
Citations141
SJR quartileQ1
SJR score19.07
SNIP10.48
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
The Nordic countries represent a survival gold standard to which other countries can aspire, and the obstacles to access and application of standard treatments probably vary markedly with country.
Abstract
The Nordic countries represent a survival gold standard to which other countries can aspire. Since most childhood cancers respond well to treatment, survival differences are attributable to differences in access (including referral and timely diagnosis) and use of modern treatments; however, the obstacles to access and application of standard treatments probably vary markedly with country.
Keywords
MedicineBiochemistry, Genetics and Molecular Biology
Journal of the Royal Statistical Society Series B (Statistical Methodology)Regression Models and Life-Tables
39,259 Citations1972D. R. Cox
International Journal of CancerThe international classification of childhood cancer
498 Citations1996E Kramárová, Charles Stiller
The International Classification of Childhood Cancer (ICCC) updates the widely used Birch and Marsden classification scheme to accommodate important changes in recognition of different types of neoplasms, while preserving continuity with the original classification.
Annals of OncologyEUROCARE-3 summary: cancer survival in Europe at the end of the 20th century
476 Citations2003Michel P. Coleman, Gemma Gatta +8 more
The mission of cancer registries should be reconsidered, and the priority shifted from classical descriptive epidemiology and geo-graphical pathology toward more analytical monitoring of progress against cancer, including the probability of survival and cure, the burden of cancer prevalence, andThe late effects of therapy.
JAMAAre Increasing 5-Year Survival Rates Evidence of Success Against Cancer?
447 Citations2000H. Gilbert Welch
Although 5-year survival is a valid measure for comparing cancer therapies in a randomized trial, the analysis shows that changes in 5- year survival over time bear little relationship to changes in cancer mortality and appear primarily related to changing patterns of diagnosis.
American Journal of Tropical Medicine and HygieneManual of the International Statistical Classification of Diseases, Injuries, and Causes of Death
358 Citations1959Lillian Guralnick
Computer Programs in BiomedicineA computer program package for relative survival analysis
349 Citations1985Timo Hakulinen, Kamal Abeywickrama
A computer program package has been constructed for use in patient survival analyses for chronic diseases based on aggregated data and it is hoped that the package will facilitate standardization of statistical methodology and terminology in long-term survival studies for chronic disease.
LeukemiaImproving outcome through two decades in childhood ALL in the Nordic countries: the impact of high-dose methotrexate in the reduction of CNS irradiation
291 Citations2000Göran Gustafsson, Kjeld Schmiegelow +9 more
In this population-based material from the five Nordic countries, 2860 children below 15 years of age were diagnosed with acute lymphoblastic leukemia from July 1981 to June 1998, the annual incidence was 3.9/100 000 children and was stable throughout the study period.
CancerChildhood cancer survival in Europe and the United States
259 Citations2002Gemma Gatta, Riccardo Capocaccia +3 more
Whether transatlantic differences in survival also are present in childhood cancers in the United States is investigated.
JNCI Journal of the National Cancer InstituteNoncancer Deaths in White Adult Cancer Patients
253 Citations1993B. W. Brown, Cássio Cassal Brauner +1 more
Because more noncancer deaths occurred shortly after diagnosis, it appears that this excess was caused by treatment of the cancer.
British Journal of CancerCentralised treatment, entry to trials and survival
252 Citations1994Charles Stiller
A review was carried out of the published literature on survival rates for cancer in relation to patterns of organisation of medical care, specifically treatment at specialist centres or at hospitals treating larger numbers of patients and treatment by protocol, usually within the context of a clinical trial.
European Journal of CancerSurvival of children with bone sarcoma in Europe since 1978
115 Citations2001Charles Stiller, A W Craft +1 more
Improvements in survival which had previously been reported from individual countries and in clinical series are confirmed as having taken place throughout much of Europe on a population basis.
European Journal of CancerSurvival of children with soft-tissue sarcoma in Europe since 1978
112 Citations2001Charles Stiller, Michaël C.G. Stevens +2 more
Improvements in survival which had previously been reported from individual countries and in clinical series are confirmed as having taken place throughout much of Europe on a population basis.
New England Journal of MedicineCancer in the Parents of Children with Cancer
94 Citations1995Jørgen H. Olsen, John D. Boice +3 more
Cancer in children should not be viewed as a general marker for an increased risk of cancer in the patient's parents, not do the patterns of incidence point to the influence of shared environmental factors.
British Journal of HaematologyCritical study of prognostic factors in childhood acute lymphoblastic leukaemia: differences in outcome are poorly explained by the most significant prognostic variables
74 Citations1998Jean Donadieu, Marie-Françoise Auclerc +11 more
The most significant prognostic factors in childhood All each explain no more than 4% of the variability in prognosis, which underlines the need for prognostic tools in childhood ALL.
CancerTrends in childhood cancer mortality as indicators of the quality of medical care in the developed world
53 Citations1998Carlo La Vecchia, Fabio Levi +4 more
This study compares the reduction of mortality from childhood cancer in general, and childhood leukemia in particular, in four economically developed areas of the world, to assess accessibility to and effectiveness of technologically advanced medical care.
European Journal of CancerSurvival of children with neuroblastoma
51 Citations2001Claudia Spix, Tiiu Aareleid +4 more
It can be assumed that in neuroblastoma, both incidence and survival are related to the frequency of diagnosing asymptomatic cases with good prognosis among infants, but one cannot ignore possible intercountry differences in the effectiveness of therapy.
European Journal of CancerChildhood cancer survival in Europe, 1978–1992
48 Citations2001J.W.W. Coebergh, R. Capocaccia +3 more
European Journal of CancerChildhood malignancies in the EUROCARE study
36 Citations2001Corrado Magnani, Gemma Gatta +5 more
The EUROCARE database represents a unique source of information on survival of childhood cancer patients in Europe, intercountry differences and time trends in survival, and the methodology used to analyse and report survival.
European Journal of CancerThe EUROCARE study of survival of cancer patients in Europe
36 Citations2001Franco Berrino, Gemma Gatta +2 more
European Journal of CancerVariation in survival of European children with acute lymphoblastic leukaemia, diagnosed in 1978–1992
35 Citations2001J.W.W. Coebergh, Guido Pastore +3 more
The 5-year survival rates for European children with acute lymphoblastic leukaemia were largely similar to those found in the USA, Canada and Australia, but markedly better than those in Japan.
Medical and Pediatric OncologyEarly deaths in childhood cancer
31 Citations2000Merlın Hamre, James R. Williams +4 more
A decrease in the proportion of early deaths associated with childhood cancer has occurred during the past 2 decades, and this decrease may reflect earlier diagnosis or improved imaging capabilities, surgical techniques, medical therapy, and supportive care.
Tumori JournalSurvival of Childhood Cancer Patients in Italy, 1978–1989
23 Citations1997Corrado Magnani, Guido Pastore +34 more
Italian survival of patients with childhood malignant neoplasms was studied and most diagnostic categories presented an improved prognosis for the cases diagnosed more recently.
European Journal of CancerThe United Kingdom children's cancer study group—the first 20 years of growth and development
22 Citations1997M.G. Mott, J R Mann +1 more
On 14 January 1977, a meeting was held in the Birmingham Children’s Hospital at which 14 members from 7 paediatric oncology units agreed to form the UKCCSG, a new national organisation required if children nationwide were going to benefit promptly from the advances being made.
European Journal of CancerSurvival of children with thyroid cancer in Europe 1978–1989
15 Citations2001Hans H. Storm, I Pleško
Survival was high during the entire study period, and variations influenced by the small numbers, but long-term follow-up beyond 10--20 years is needed to clearly demonstrate excess mortality as a consequence of the cancer.
The LancetEUROCARE-2: relevance for assessment of quality of cancer services?
14 Citations2000Les Irwig, Bruce K. Armstrong
International Journal of CancerEarly and late deaths after elective end of therapies for childhood cancer in Italy
14 Citations2000Riccardo Haupt, M. G. Valsecchi +7 more
Long‐term survival and causes of death were evaluated in a cohort of subjects treated for childhood cancer who reached the elective end of therapy in continuous remission and were registered until 1992 in the Italian Registry of off‐therapy subjects (OTR).
CancerHow to judge the cancer services benefit component of your health insurance plan
10 Citations1998Lee E. Mortenson
Members of the oncology community, rich in data from years of published clinical research, epidemiology, and tumor registry information, expect businesses to evaluate the quality of cancer care using classic scientific methods, but businesses lack sophistication in these data and tend to use significantly different criteria relating to cost, service, and access.